New Search

If you are not happy with the results below please do another search

56 search results for:

1

oneRay LMR

LMR Precision AI Legal, Medical & Regulatory Review Legal, Medical & Regulatory Review, Reimagined with AI Accelerate Legal, Medical & Regulatory review with AI-powered annotations, Veeva integration, and automated approval workflows. Request a Demo oneRay LMR at a Glance Veeva AI Partner VeevaIntegrated Fully integrated with Veeva RIM, PromoMats & Vault Stand-alone Also available as [...]
2

oneRay Dossier Builder

Dossier Builder AI-Powered Dossier Builder Dossier Builders, Reimagined with AI Accelerate Dossier Builder development with AI-powered evidence compilation, dynamic content assembly, and automated market access documentation across global markets. Request a Demo oneRay Dossier Builder at a Glance 65% Effort reduction, with humans in the lead 70% Shortening of the entire process, reducing time to [...]
3

oneRay SLR

SLR Precision AI Literature Review Systematic Literature Reviews, Reimagined with AI Accelerate evidence synthesis with AI-powered screening, data extraction, and automated reporting across regulatory and medical workflows. Request a Demo oneRay SLR at a Glance 75% Effort reduction while keeping humans in the lead 85% Shortening of the entire process and accelerating drugs to market [...]
4

Human in the Lead: Why the AI Advantage Belongs to Those Who Lead It

AI is rapidly entering life sciences. Research, medical writing, regulatory affairs, market access — few functions are untouched by the conversation. The technology is advancing fast, investment is accelerating, and the pressure to act is real. But speed of adoption and quality of results are not the same thing. And in a highly regulated industry [...]
7

Why Pharma Can’t Afford Good Enough AI

Why Pharma Can't Afford 'Good Enough' AI Generic AI tools like ChatGPT and Microsoft Copilot are rapidly being adopted across pharmaceutical organizations, with teams expecting them to handle complex use cases involving internal medical data. Yet despite their promise, these tools frequently fall short in pharmaceutical, biotech, and medtech environments. While they excel at general [...]
8

H2 2025 & 2026 AI Implementation Opportunities: Strategic Planning for Proven ROI in Pharma, Biotech & Medtech

As life sciences organizations allocate H2 2025 and 2026 budgets, the question isn't whether to invest in generative AI - it's how to implement it strategically for maximum impact. The Strategic Foundation: More Than Just Technology At FFI Ventures, we've learned that successful AI implementation requires a comprehensive approach that goes far beyond deploying tools. [...]
9

OneRay Key Updates Delivering Next-Generation GenAI Capabilities

OneRay Key Updates Delivering Next-Generation GenAI Capabilities   Our private gen AI solution OneRay comes with significant updates in Version 3, introducing enhanced AI capabilities and an expanded suite of specialized agents for pharmaceutical knowledge work. We're pleased to share the key updates now available in OneRay Version 3, delivering a series of transformative enhancements [...]